There is a reason Texas Biomedical Research Institute is at the forefront of participating in some of the most advanced preclinical research in the world when it comes to combating infectious diseases and pandemics from COVID-19 to tuberculosis.
Services
- Contract research organization
- Academic research and development study design and management
- In vitro/in vivo diagnostic, therapeutic, and vaccine development
- Efficacy/safety testing
- Molecular/cellular assays
- Disease model expertise
- Scientific publications
- Grant support
Research Capabilities
- Research partnerships
- Emerging infectious diseases (SARS, SARS-CoV-2, Zika)
- Leading infectious diseases (HIV, TB, Malaria)
- Hemorrhagic fever viruses (Ebola, Marburg, Lassa)
- Aging and development
- Neurological disorders
- Host-Pathogen Interactions
- Disease Intervention
- Population Health
Resources
- High Containment ABSL 3 and ABSL 4 biomedical research laboratories
- Select agent registration
- Southwest National Primate Research Center
- Multi-species vivarium (mouse, rat, hamster, guinea pig, rabbits, ferrets)
- Positron emission tomography–computed tomography (PET/CT)
- In vivo imaging systems (IVIS)
- Veterinary pathologists for histology scoring
- Preclinical research reagent sharing portal
- Biomedical research cores: biology, molecular, and microscopy